Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
AstraZeneca PLC ADR
AZNCurrent price
85.89 USD
+0.01 USD (+0.01%)
Last closed
85.56 USD
Company
www.astrazeneca.com
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NASDAQ
Capitalization
265 282 191 360 USD
Yield for 12 month
+24.30 %
1Y
3Y
5Y
10Y
15Y
AZN
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; and BenevolentAI for drug discovery for systemic lupus erythematosus. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom. Address: 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
90.65 USDP/E ratio
41.534Dividend Yield
1.74 %Current Year
+45 811 000 000 USD
Last Year
+44 351 000 000 USD
Current Quarter
+12 938 000 000 USD
Last Quarter
+12 938 000 000 USD
Current Year
+37 543 000 000 USD
Last Year
+31 960 000 000 USD
Current Quarter
+9 793 000 000 USD
Last Quarter
+9 793 000 000 USD
Key Figures AZN
1 year
3 years
5 years
10 years
EBITDA
16 972 999 680 USD
Operating Margin TTM
PE Ratio
41.534
Return On Assets TTM
7.68 %
PEG Ratio
1.0658
Return On Equity TTM
16.74 %
Wall Street Target Price
90.65 USD
Revenue TTM
49 132 998 656 USD
Book Value
25.49 USD
Revenue Per Share TTM
Dividend Share
2.97 USD
Quarterly Revenue Growth YOY
13.3 %
Dividend Yield
1.74 %
Gross Profit TTM
35 732 000 000 USD
Earnings per share
2.06 USD
Diluted Eps TTM
2.06 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
6 %
Profit Margin
13.11 %
Dividend Analytics AZN
Dividend growth over 5 years
6 %Continuous growth
1 yearPayout Ratio 5 years average
834 %Dividend History AZN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
1.49
Ex Dividend Date
09.08.2024
Forward Annual Dividend Yield
1.74 %
Last Split Factor
2:1
Payout Ratio
41.02 %
Last Split Date
27.07.2015
Dividend Date
09.09.2024
Stock Valuation AZN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
41.534
Forward PE
20.3666
Enterprise Value Revenue
5.8848
Price Sales TTM
5.3993
Enterprise Value EBITDA
20.5266
Price Book MRQ
6.714
Financials AZN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators AZN
For 52 weeks
59.19 USD
86.04 USD
50 Day MA
79.78 USD
Shares Short Prior Month
5 801 873
200 Day MA
71.3 USD
Short Ratio
1.87
Shares Short
5 707 953
Short Percent
0.27 %
BeatStart